Basilea Pharmaceutica AG
BPMUFOTCHealthcare● Active
$65.10
$-0.00(-0.00%)
Market Cap$805588844
P/E Ratio—
52W High$74
52W Low$47.5
Basilea Pharmaceutica AG（BPMUF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BPMUF · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.23B | $0.21B | $0.16B | $0.15B | $0.15B |
| Cost of Revenue | $0.04B | $0.04B | $0.03B | $0.02B | $0.02B |
| Gross Profit | $0.19B | $0.17B | $0.13B | $0.12B | $0.12B |
| Gross Margin %(computed) | 83.09% | 81.45% | 83.00% | 83.35% | 83.75% |
| Operating Expenses | |||||
| R&D Expenses | $0.11B | $0.08B | $0.08B | $0.07B | $0.09B |
| G&A Expenses | $0.00B | $0.03B | $0.03B | $0.03B | $0.03B |
| Total Operating Expenses | $0.14B | $0.11B | $0.11B | $0.03B | $0.03B |
| Operating Income | $0.05B | $0.06B | $0.02B | $0.02B | $0.00B |
| Operating Margin %(computed) | 22.20% | 29.34% | 12.18% | 12.55% | 0.80% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.01B | $0.01B | $0.01B |
| Income Before Tax | $0.05B | $0.06B | $0.01B | $0.01B | ($0.01B) |
| Income Tax Expense | $0.01B | ($0.02B) | $0.00B | ($0.00B) | $0.00B |
| Net Income | $0.04B | $0.08B | $0.01B | $0.01B | ($0.01B) |
| Net Margin %(computed) | 17.30% | 37.21% | 6.63% | 8.22% | -4.61% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $3.29 | $6.42 | $0.86 | $1.02 | $-0.58 |
| Wtd Avg Shares | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B |
| EBITDA | $0.05B | $0.07B | $0.02B | $0.02B | $0.00B |
| EBITDA Margin %(computed) | 22.20% | 31.81% | 14.74% | 14.69% | 2.40% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · CHF · B
深入了解Basilea Pharmaceutica AG
关于Basilea Pharmaceutica AG（BPMUF）损益表
Basilea Pharmaceutica AG（BPMUF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，BPMUF实现营收$0.23B，毛利润$0.19B（毛利率83.09%），净利润$0.04B（净利率17.30%）。
常见问题
BPMUF · 4 问Basilea Pharmaceutica AG（BPMUF）2025财年营收为$0.23B，同比up11.5%。
BPMUF revenueBPMUF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09